EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE
Clinical trials for EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE explained in plain language.
Never miss a new study
Get alerted when new EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE trials appear
Sign up with your email to follow new studies for EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to wipe out Early-Stage lymphoma
Disease control Recruiting nowThis study is testing an investigational drug called epcoritamab in adults who have just been diagnosed with marginal zone lymphoma (MZL) and have not yet received any treatment. The main goal is to see how many participants achieve a complete response, meaning no detectable canc…
Matched conditions: EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE
Phase: PHASE2 • Sponsor: Izidore Lossos, MD • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New 'Living Drug' trial targets advanced blood cancers
Disease control Recruiting nowThis early-stage trial is testing a new type of cell therapy for adults with certain blood cancers that have returned or not responded to standard treatments. Doctors modify a patient's own immune cells (T cells) in a lab to better recognize and attack cancer cells, then infuse t…
Matched conditions: EXTRANODAL MARGINAL ZONE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID TISSUE
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC